Description: Appointed actuaries are facing a number of changes in the regulatory landscape. Some of these occurred in the past few years, such as AG51 (Asset Adequacy Testing for LTC). Some were very recently put in effect and are evolving, such as AG53 (Modeling and Documentation of Complex Assets). Some are quickly approaching, such as the potential changes to asset adequacy testing requirements for reinsurance ceded by life insurers. In addition, changes to qualification requirements are on the horizon. Hear from appointed actuaries about the challenges they’ve experienced and how they’ve worked through them. Also, learn what challenges and opportunities they see in the near future and how they are preparing for coming changes.

Description: The recent round of regulatory changes (LDTI, IFRS 17, PBR) has put a demand on actuarial organizations, and in particular, financial reporting functions unlike most have experienced in their careers. With adoption, where does this leave the financial reporting function going forward? What work is left to be done? How will the financial reporting function need to evolve under these accounting regimes? Come explore these topics and more through a moderated debate, inclusive of the following questions: - What are the biggest 'day 2' items that remain on your organization's 'to-do' list? - How are valuation actuaries equipped to navigate the newly available data, understand the results, and tell the underlying earnings story? - How do new regulatory requirements fit into current close calendar requirements? - What are the peripheral impacts from regulatory change (e.g., FP&A, product development) and how are your valuation actuaries involved in these processes?

Description: IFRS 17 will be effective as of 1 Jan 2023 and provide opportunities as well as challenges to both Direct Writers and Reinsurers across the insurance industry. If the new framework is not fully understood, an implementation can elevate the risk of problems in financial reporting, product development, investment management and more. The transition to IFRS provides an opportunity for companies to optimize the financial position of the enterprise by implementing mitigating strategies to reduce the risks and challenges that IFRS brings to the table.

Description: June 2024, AG54 will begin for new RILA sales. This guidance requires companies to determine an interim value that is more aligned with the market value of the position on a daily basis. This discussion will talk through companies adoption of AG54, lessons learned, approaches and integration with the administration system. Additionally this session will discuss how AG54 impacts new product design, reserving and capital implications.

Description: As companies strive to remain competitive in today's dynamic marketplace, the role of Financial Planning & Analysis (FP&A) has evolved significantly. It has transitioned from a purely operational function to a strategic imperative. This is most apparent in the life insurance sector, where complex regulatory changes and technological advancements are reshaping traditional practices. In this session, we will delve into the critical aspects of modernizing FP&A within the life insurance industry, exploring key challenges, emerging trends, and best practices. Key areas of discussion include: - Navigating Different Regulatory Frameworks: Companies have to navigate different regulatory lenses for various purposes including budgeting, capital management, rating agencies review, etc. The implementation of regulatory frameworks such as IFRS 17, LDTI, and Principles-Based Reserves (PBR), and the recent trend in establishing Bermuda entities has significant implications for financial reporting and capital management in the life insurance sector. We will discuss how companies can explore strategies for compliance and adaptation within the FP&A process. - Strategic Planning and Resource Allocation: Companies are faced with higher expectations to guide both internal and external parties on the financial impact of their plans. A comprehensive exploration enabled by advanced analytics is critical for communicating, prioritizing, and allocating a company's resources on transactions, product development, and capital management. Our panel will explore how strategic planning has advanced in recent years, providing insights into effective approaches for aligning strategic objectives with financial resources. - Technological Advancements: The rapid pace of technological innovation has opened new possibilities for FP&A, offering advanced modeling techniques and data analytics capabilities. However, many organizations face challenges in harnessing these technologies effectively. This session will examine the role of technology in modernizing FP&A and highlight best practices for implementation. By attending this session, participants will gain: - Strategies for aligning strategic planning with resource allocation and effectively communicating financial impacts to internal and external stakeholders. - An understanding of the current state of FP&A within the life insurance industry, including emerging trends and challenges. - Insight into the implications of regulatory and technological advancements on FP&A processes and functions. - Best practices for leveraging technology to enhance FP&A capabilities and drive strategic decision-making.

Description: Historically for coinsurance deals some appointed actuaries have only concerned themselves with the reinsurer counterparty risk and in certain cases have ignored 100% coinsurance business in their asset adequacy analyses (AAA). Recently there have been regulatory discussions about concerns relating to asset intensive reinsurance and how these deals may be exposing policyholders to additional risk. Presenters will discuss the recent draft APF 2024-3 and issue brief 'Asset-Intensive Reinsurance Ceded Offshore From U.S. Life Insurers (With Focus on Bermuda)', potential impact to AAA, and modeling considerations.

Description: Join this discussion on Valuation topics from both a GAAP and Statutory basis with a spin on how to communicate them to a non-Actuarial and leadership audience. It will include, but certainly not limited to, discussion on IBNR analysis, PAD and its purpose, Wallstreet metrics such as Days in Claims Payable and Medical Claims Payable Growth vs Premium and Membership Growth. The key here is to not only educate on the Valuation processes and metrics, but also to show the best ways to communicate them so that a less technical audience can interpret the impact and make better strategic decisions. It is also to show the importance of the Valuation reserves on the balance sheet and income statements in regards to a Public company and how WallStreet interprets the numbers.

Description: Join us for an engaging session packed with practical tips and interactive discussions to help you unlock the true potential of the investment in being LDTI ready and unleash its full potential.

Description: Take part in a practical and forward-looking discussion for long duration targeted improvements (LDTI) implications on financial planning and analysis (FP&A). This session will provide an update on emerging industry practices and considerations for reflecting LDTI in FP&A, including operational headwinds and new opportunities.

Description: Delve into the nexus of actuarial science in the heart of D.C. This session offers an in-depth look at the sophisticated mechanics behind additional health insurance reserves, framed by the unique regulatory landscape of national policy. As we explore premium deficiency reserves and additional reserve requirements, attendees will understand how regulatory oversight and frameworks influence these critical actuarial items. Through engaging discussions and case studies, we'll uncover the strategic intersections between actuarial decisions and policy implications, offering insights into effectively navigating the complexities of governance and regulation as they relate to additional health insurance reserve. Join us for a compelling journey through the art and science of actuarial work in the political arena.